In both benign and malignant colon cancers, tumor-associated stromal expression of COX-2 resulted in elevated levels of PGE2 that stimulated the PG receptor, EP-2, followed by induction of VEGF-A production that promoted tumor angiogenesis [129]. The gene discussed is VEGFA; the disease is neoplasm.